How Air Ambulance Brokerage ParaFlight Took Wing

ParaFlight, the New Jersey-based air ambulance brokerage founded by Sim Shain in 2014, has grown from five charters in its inaugural year to a 24/7 operation logging roughly 1,500 flights annually by the close of 2025. The company operates not as a traditional air carrier but as a demand-aggregation and dispatch platform, connecting time-sensitive mission requests with vetted charter operators through two proprietary digital tools: OrganFlights.com and UrgentFlights.com. Those platforms broadcast trip requirements to hundreds of participating operators in under two minutes, enabling ParaFlight to launch missions within minutes of receiving a request—including late-night, weekend, and holiday departures. The flight mix spans human organ and transplant-team transport, critical care patient transfers, corporate executive travel, government operations, and expedited cargo, reflecting a business model built on urgency across multiple verticals simultaneously.

The organ transport segment of ParaFlight's book of business imposes some of the most unforgiving time constraints in commercial aviation. A procured human heart carries a viability window of approximately four hours from harvest to implantation; a lung extends that margin to roughly six hours. Those physiological deadlines drive mission profiles that leave no room for scheduling delays, crew rest miscalculations, or aircraft availability gaps. For charter operators participating in OrganFlights.com, acceptance of these missions demands rigorous on-call crew structures, pre-positioned aircraft, and maintenance readiness standards that mirror the operational tempo of scheduled air carriers—without the schedule predictability that carriers use to plan those resources. The brokerage model ParaFlight employs means that individual operators absorb the direct regulatory and safety risk while gaining access to a high-volume, high-urgency demand stream they could not efficiently source independently.

The company's origin story illustrates a trajectory that shaped the broader air ambulance and medical charter sector over the past two decades. Steve Zakheim's philanthropic use of a Learjet 31—fitted with a stretcher and supplemental oxygen and operated outside any commercial revenue structure—represents an early, informal version of what has since become a formalized and regulated niche within Part 135 charter operations. Zakheim's aircraft existed purely as a humanitarian tool, financed by private wealth rather than reimbursement systems. Shain's subsequent professionalization of the model, anchored initially by the institutional relationship with Montefiore Medical Center, marks the transition from philanthropic impulse to scalable commercial infrastructure. That transition reflects the industry's broader shift toward hospital-system partnerships and managed transport agreements as the primary revenue engine for medical charter operations.

For operators and pilots working Part 135, ParaFlight's platform-based dispatch model represents a structural change in how ad-hoc and urgent charter demand is surfaced and allocated. Historically, organ and medical transport missions moved through direct hospital relationships or regional air ambulance networks with limited transparency. Broadcast platforms that reach hundreds of operators in seconds introduce a degree of price competition and speed-of-response pressure that rewards operators who have invested in crew availability systems and aircraft-readiness protocols. Pilots flying for operators participating in these networks should expect mission activation timelines measured in minutes rather than hours, and should anticipate patient or organ transport as a distinct operational category requiring familiarity with medical crew integration, specialized loading procedures, and the regulatory distinctions governing air ambulance versus standard charter configurations. The continued growth of brokerage intermediaries like ParaFlight suggests that this demand aggregation model is becoming a durable feature of the medical charter landscape rather than an anomaly.